US VASCULAR INC

US VASCULAR INC specializes in the design and manufacturing of advanced surgical and medical instrumentation, with a focused expertise in non-invasive physiologic testing systems for vascular diagnostics. The company develops precision-engineered devices such as the VASCULAB GSX, a clinical-grade system designed to evaluate peripheral artery disease through automated waveform analysis, ankle-brachial index measurement, and segmental pressure assessment. Their technical capabilities encompass biomedical signal processing, sensor integration, and FDA-regulated medical device development, ensuring compliance with ISO 13485 and IEC 60601 standards. Differentiators include proprietary algorithms for arterial flow analysis and ruggedized hardware tailored for high-throughput vascular labs and military medical environments. The contractor’s sole recorded contract history is with the Department of Defense, indicating a targeted engagement in equipping military medical facilities with diagnostic tools for combat-related vascular injuries and veteran care programs. Their work supports frontline vascular screening in field hospitals and VA-affiliated clinics, emphasizing durability, portability, and ease of use in austere conditions. US VASCULAR INC operates within NAICS 339112, positioning itself as a niche manufacturer of diagnostic medical devices rather than broad-spectrum healthcare equipment. The company’s vertical specialization lies in peripheral vascular assessment technology, serving clinical and defense markets that require validated, non-invasive tools for early detection of arterial occlusion and ischemia. As a small business structured as a 2L entity based in Beaverton, Oregon, US VASCULAR INC maintains a focused, agile operational model. While currently unaffiliated with formal government certifications such as 8(a), HUBZone, or SDVOSB, its product development lifecycle adheres to federal medical device regulatory requirements. The company’s geographic proximity to Pacific Northwest biomedical research hubs enhances its capacity for innovation in diagnostic instrumentation.